Welcome to LookChem.com Sign In|Join Free

CAS

  • or

321574-29-2

Post Buying Request

321574-29-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

321574-29-2 Usage

General Description

1-[(ammoniooxy)methyl]-4-(trifluoromethyl)benzene chloride is a chemical compound with a molecular formula C8H8ClF3NO. It is a benzene derivative that contains a chlorine atom and a trifluoromethyl group attached to the benzene ring. The compound also features an ammoniooxy group, which is a nitrogen atom bonded to an oxygen atom and then connected to a methyl group. This chemical is often used in organic synthesis and as a reagent in chemical reactions. It may also have applications in pharmaceutical and agrochemical industries, as well as in the production of various materials and compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 321574-29-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,1,5,7 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 321574-29:
(8*3)+(7*2)+(6*1)+(5*5)+(4*7)+(3*4)+(2*2)+(1*9)=122
122 % 10 = 2
So 321574-29-2 is a valid CAS Registry Number.

321574-29-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name O-[[4-(trifluoromethyl)phenyl]methyl]hydroxylamine,hydrochloride

1.2 Other means of identification

Product number -
Other names O-[[4-(Trifluoromethyl)phenyl]methyl]hydroxylamine hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:321574-29-2 SDS

321574-29-2Downstream Products

321574-29-2Relevant articles and documents

Synthesis and anti-tumor activity evaluation of salinomycin C20-O-alkyl/benzyl oxime derivatives

Duan, Wenfang,Hao, Jie,Hu, Yuhua,Li, Bo,Li, Tianlei,Li, Zhongwen,Lian, Xu,Qin, Tong,Tang, Lei,Wu, Jun,Wu, Song,Zhang, Chi,Zhang, Jihong,Zhang, Wenxuan,Zhao, Xintong

, p. 870 - 876 (2022/02/03)

Seventeen C20-O-alkyl/benzyl oxime derivatives were synthesized by a concise and effective method. Most of these derivatives showed tens to several hundred nanomolar IC50 values against HT-29 colorectal, HGC-27 gastric and MDA-MB-231 breast cancer cells, whose antiproliferative activity is 15-240 fold better than that of salinomycin. The C20-oxime etherified derivatives can coordinate potassium ions, and further adjust the cytosolic Ca2+ concentrations in HT-29 cells. The significant improvement of the potency should be attributed to the better ion binding and transport ability of the modified derivatives. In addition, the C20-O-alkyl/benzyl oxime derivatives showed much better selectivity indexes (SI) than salinomycin, indicating that they present lower neurotoxic risk.

Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents

Fan, Yi-Lei,Wu, Jian-Bing,Ke, Xing,Huang, Zhong-Ping

supporting information, p. 3064 - 3066 (2018/08/21)

A series of oxime-functionalized nitrofuranylamides were designed, synthesized and evaluated for their in vitro anti-mycobacterial activities against MTB H37Rv and drug-resistant clinical isolates. Among them, two compounds 7a and 7b exhibited excellent activity against the three tested strains. Both of them were comparable to the first-line anti-TB agents INH and RIF against MTB H37Rv, and were far more potent than INH and RIF against MDR-TB 16833 and 16995 strains. Thus, both of them could act as leads for further optimization.

OXIMINO DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA

-

Paragraph 0214; 0215, (2016/04/19)

Compounds of the general formula (I), including their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds and the intermediates involved in their preparation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 321574-29-2